Patents by Inventor Werner Haberbosch

Werner Haberbosch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
    Patent number: 8158142
    Abstract: A stent is coated with 3-deazaadenosine or an analog of 3-deazaadenosine for the prevention and/or treatment of vascular disease or graft rejection.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: April 17, 2012
    Assignee: Kerckhoff-Klinik Gesellschaft mit beschrankter Haftung
    Inventor: Werner Haberbosch
  • 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
    Patent number: 7785614
    Abstract: The invention relates to the use of 3-deazaadenosine and analogs thereof for the manufacture of a medicament against vascular diseases or graft rejection.
    Type: Grant
    Filed: September 4, 2003
    Date of Patent: August 31, 2010
    Assignee: Kerckhoff-Klinik Gesellschaft Mit Beschränkter Haftung
    Inventor: Werner Haberbosch
  • 3-Deazaadenosine prevents atherosclerosis and graft vasculopathy
    Publication number: 20100106244
    Abstract: A stent is coated with 3-deazaadenosine or an analog of 3-deazaadenosine for the prevention and/or treatment of vascular disease or graft rejection.
    Type: Application
    Filed: November 4, 2009
    Publication date: April 29, 2010
    Inventor: Werner Haberbosch
  • 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
    Publication number: 20040106563
    Abstract: The invention relates to the use of 3-deazaadenosine and analogs thereof for the manufacture of a medicament against vascular diesases or graft rejection.
    Type: Application
    Filed: September 4, 2003
    Publication date: June 3, 2004
    Inventor: Werner Haberbosch
  • 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
    Patent number: 6693088
    Abstract: Vascular diseases and graft rejection are treated or prevented with 3-deazaadenosine and analogs thereof.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: February 17, 2004
    Assignee: Kerckhoff-Klinik Gesellschaft MIT Beschränkter Haftung
    Inventor: Werner Haberbosch
  • Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties
    Patent number: 6517858
    Abstract: The invention relates to a bioactive implant comprising a substrate coated with a polymer layer with reactive functions, and a bioactive substance fixed on the implant by means of said reactive functions to enable progressive release on the implant site. Such implants are useful in the field of cardiology for example to prevent restenosis resulting from the fitting of stents in the coronary arteries.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: February 11, 2003
    Assignees: Commissariat a L'Energie Atomique, Institut National de la Sante et de la Recherche Medicale, Kerckhoff-Klinik GmbH
    Inventors: Alain Le Moel, Natacha Betz, Christophe Bureau, Guy Deniau, Charles Baquey, Gérard Deleris, Werner Haberbosch